Bain Capital Life Sciences Investors, LLC
CIK: 0001703031SEC EDGAR →
Portfolio Value
$1.3B
Holdings
19
As of
Q4 2025
New Positions
2
Closed Positions
3
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | HEARTFLOW INC | 12,448,158 | $362.9M | 27.79% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | 7,306,566 | $256.3M | 19.63% |
| 3 | OLEMA PHARMACEUTICALS INC | 8,508,641 | $212.7M | 16.29% |
| 4 | SAVARA INC | 17,600,621 | $106.1M | 8.13% |
| 5 | PHARVARIS N V | 2,802,081 | $77.8M | 5.96% |
| 6 | SOLID BIOSCIENCES INC | 7,911,669 | $44.6M | 3.42% |
| 7 | UPSTREAM BIO INC | 1,329,544 | $36.1M | 2.76% |
| 8 | X4 PHARMACEUTICALS INC | 7,967,454 | $31.9M | 2.44% |
| 9 | DIANTHUS THERAPEUTICS INC | 743,592 | $30.6M | 2.35% |
| 10 | KYVERNA THERAPEUTICS INC | 3,110,000 | $29.2M | 2.24% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 17 | $1.2B | 91.1% |
| Unknown | 2 | $116.2M | 8.9% |